Inactive Instrument
Stemcell Holdings, Inc. Stock Other OTC
Stocks
STMM
US85858N2027
Pharmaceuticals
OTC Markets Traded| Manager | Title | Age | Since |
|---|---|---|---|
Masato Ozawa
CEO | Chief Executive Officer | 67 | 24/05/2021 |
Gabriel Garcia
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kato Hirotaro
LAW | General Counsel | - | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -.--% | - | - | 1.64M | |
| +1.18% | +3.29% | +42.02% | -1.35% | 79.68B | |
| -3.73% | +3.89% | -1.33% | +25.77% | 50.61B | |
| -0.77% | -2.18% | +15.66% | +167.96% | 48.81B | |
| -0.66% | +3.90% | -48.98% | -47.71% | 46.91B | |
| +0.83% | +1.81% | +55.34% | -23.00% | 30.86B | |
| +1.03% | +18.25% | +136.85% | -36.31% | 25.42B | |
| +0.06% | +1.39% | +39.81% | +83.98% | 24.48B | |
| -0.42% | +4.62% | +0.16% | +193.67% | 21.2B | |
| -0.56% | +1.38% | +66.61% | +166.05% | 16.39B | |
| Average | -0.39% | +3.56% | +34.02% | +58.79% | 38.26B | |
| Weighted average by Cap. | -0.43% | +3.17% | +26.15% | +41.84% |
| 2016 | 2017 | |
|---|---|---|
| Net sales | 3.34M 2.89M 2.71M 2.47M 4.65M 318M 4.72M 31.88M 12.46M 159M 12.54M 12.26M 532M | 6.18M 5.35M 5.02M 4.58M 8.6M 589M 8.73M 59M 23.06M 295M 23.2M 22.7M 984M |
| Net income | 1.4M 1.22M 1.14M 1.04M 1.95M 134M 1.98M 13.39M 5.23M 66.98M 5.27M 5.15M 223M | 2.41M 2.09M 1.96M 1.78M 3.35M 230M 3.41M 23.01M 8.99M 115M 9.05M 8.85M 384M |
| Net Debt | - | - |
Employees
-
Sector
Pharmaceuticals
